Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by HighteawithIntrepidon Feb 24, 2018 9:07am

113 Views

Post# 27613881

RE:RE:RE:RE:RE:By the Numbers - No Pump Just Facts

Google this and you will see that the ability to buy our products won’t be available
to these countries and probably will be restricted to the wealthiest 5% of the world
so 25 times the US is pie in the sky. But until we get a yes on or about April 14
this is academic.